thalidomide and Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis

thalidomide has been researched along with Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis in 2 studies

Thalidomide: A piperidinyl isoindole originally introduced as a non-barbiturate hypnotic, but withdrawn from the market due to teratogenic effects. It has been reintroduced and used for a number of immunological and inflammatory disorders. Thalidomide displays immunosuppressive and anti-angiogenic activity. It inhibits release of TUMOR NECROSIS FACTOR-ALPHA from monocytes, and modulates other cytokine action.
thalidomide : A racemate comprising equimolar amounts of R- and S-thalidomide.
2-(2,6-dioxopiperidin-3-yl)-1H-isoindole-1,3(2H)-dione : A dicarboximide that is isoindole-1,3(2H)-dione in which the hydrogen attached to the nitrogen is substituted by a 2,6-dioxopiperidin-3-yl group.

Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis: Group of systemic vasculitis with a strong association with ANCA. The disorders are characterized by necrotizing inflammation of small and medium size vessels, with little or no immune-complex deposits in vessel walls.

Research

Studies (2)

Authors

Reviews

1 review available for thalidomide and Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis

Other Studies

1 other study available for thalidomide and Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis